China Golden Classic Group Limited (8281.HK)
HKD 0.11
(10.0%)
HKD 0.11
(10.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -71.51 Million CNY | -30.63% |
| 2022 | -54.74 Million CNY | -2.14% |
| 2021 | -53.59 Million CNY | 1.92% |
| 2020 | -54.64 Million CNY | -162.91% |
| 2019 | -20.78 Million CNY | -533.47% |
| 2018 | -3.28 Million CNY | 82.03% |
| 2017 | -18.25 Million CNY | 30.14% |
| 2016 | -26.13 Million CNY | -661.32% |
| 2015 | 4.65 Million CNY | -67.63% |
| 2014 | 14.38 Million CNY | 68.86% |
| 2013 | 8.51 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -50.66 Million CNY | 0.94% |
| 2024 Q1 | -50.66 Million CNY | 29.15% |
| 2023 Q2 | -21.94 Million CNY | -128.34% |
| 2023 Q4 | -71.51 Million CNY | -263.35% |
| 2023 Q3 | 43.77 Million CNY | 299.44% |
| 2023 FY | -71.51 Million CNY | -30.63% |
| 2023 Q1 | 77.43 Million CNY | 241.46% |
| 2022 Q4 | -54.74 Million CNY | -259.34% |
| 2022 Q2 | -31.29 Million CNY | 0.0% |
| 2022 FY | -54.74 Million CNY | -2.14% |
| 2022 Q3 | 34.35 Million CNY | 209.79% |
| 2021 FY | -53.59 Million CNY | 1.92% |
| 2021 Q2 | -34.45 Million CNY | 0.0% |
| 2021 Q4 | -53.59 Million CNY | 0.0% |
| 2020 Q2 | 13.86 Million CNY | 0.0% |
| 2020 Q4 | -54.64 Million CNY | 0.0% |
| 2020 FY | -54.64 Million CNY | -162.91% |
| 2019 Q2 | -6.35 Million CNY | 0.0% |
| 2019 FY | -20.78 Million CNY | -533.47% |
| 2019 Q4 | -20.78 Million CNY | 0.0% |
| 2018 Q4 | -3.28 Million CNY | 0.0% |
| 2018 FY | -3.28 Million CNY | 82.03% |
| 2018 Q2 | 29.56 Million CNY | 0.0% |
| 2017 FY | -18.25 Million CNY | 30.14% |
| 2017 Q2 | 15.74 Million CNY | 0.0% |
| 2017 Q4 | -18.25 Million CNY | 0.0% |
| 2016 FY | -26.13 Million CNY | -661.32% |
| 2016 Q2 | 41.87 Million CNY | 0.0% |
| 2016 Q4 | -26.13 Million CNY | 0.0% |
| 2015 Q4 | 4.65 Million CNY | 0.0% |
| 2015 FY | 4.65 Million CNY | -67.63% |
| 2014 FY | 14.38 Million CNY | 68.86% |
| 2013 FY | 8.51 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 27.54 Million HKD | 359.621% |
| Innovative Pharmaceutical Biotech Limited | 914.37 Million HKD | 107.821% |
| China Overseas Nuoxin International Holdings Limited | 9.99 Million HKD | 815.744% |
| Prosperous Future Holdings Limited | -337.41 Million HKD | 78.807% |
| Huasheng International Holding Limited | 175.03 Million HKD | 140.854% |
| Fourace Industries Group Holdings Limited | -250.33 Million HKD | 71.434% |
| Evergreen Products Group Limited | 430.83 Million HKD | 116.598% |
| EC Healthcare | 1.05 Billion HKD | 106.81% |
| Ming Fai International Holdings Limited | -329.49 Million HKD | 78.297% |
| Blue Moon Group Holdings Limited | -4.18 Billion HKD | 98.291% |
| SuperRobotics Holdings Limited | 126.44 Million HKD | 156.556% |
| Takbo Group Holdings Limited | -175.44 Million HKD | 59.24% |
| Hyfusin Group Holdings Limited | -318.4 Million HKD | 77.541% |